Upon further evaluation, we also found HPRT1 expression to be higher in other carcinomas and adenocarcinomas and observed that higher HPRT1 expression is closely associated with poorer clinical outcomes (Figure 6). This evidence concerns the gene HPRT1 and carcinoma.